Blood Screening Market: Current Analysis and Forecast (2021-2027)

$3999$7577

Emphasis on Product (Reagents & Kits, Instruments, Software & Services); Technology (Nucleic Acid Amplification (NAAT), Enzyme Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blotting, Next Generation Sequencing (NGS); End User (Hospitals, Blood Banks, Others); Region/Country

Published:

Nov-2021

Pages:

346

Table:

62

Figure:

152

Report ID:

UMHE21515

Geography:

Clear
  Get a Free Sample
SKU: UMHE21515 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Blood Screening Market 1
Blood Screening Market 1

Blood Screening Market is expected to grow at a CAGR of around 10% over the forecast period (2021-2027). Blood Screening is most preferred techniques for diagnosing numerous infectious diseases. Blood screening allows doctors to accurately diagnose diseases, which aids in the administration of appropriate medicines and patient monitoring to prevent disease spread. The market is being driven by factors such as an increase in blood donations and blood transfusion-related tests, an increase in the frequency of infectious diseases, a growing elderly population, and more awareness of transfusion-transmitted diseases.

The rising occurrences of novel infections, rising levels of investment for the development of sophisticated technologies, and favorable government regulations regarding blood screening would likely accelerate the expansion of the blood screening market. On the other hand, the expanding healthcare industry, combined with technological advancements, will promote different prospects, resulting in the rise of the blood screening market throughout the forecast period. In addition, the high costs associated with blood sampling are expected to limit the growth of the blood screening market during the projected period.

Prevalence of Diagnosed Infectious Diseases in Selected Countries, (%), 2019

Blood Screening Market 2
Blood Screening Market 2

Some of the major players operating in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson And Company, Thermo Fisher Scientific Inc., bioMerieux, Inc., Grifols, S.A., Danaher Corporation, Boster Biological Technology, Demeditec Diagnostics GmbH, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

“Amongst Product, Reagents & Kits segment dominated the market in 2020”

Based on Product, the Blood Screening Market is segmented into Reagents & Kits, Instruments, Software & Services. In 2020, the reagents & kits category held the greatest proportion of the global blood screening market. Reagents are frequently utilized in immunoassays and molecular diagnostics since they constitute a recurring cost. The expansion of this market is being fueled by factors such as rising blood donations and transfusion-related screenings, as well as the rising prevalence of infectious & chronic diseases globally.

“Amongst Technology, Nucleic Acid Amplification (NAAT) segment dominated the market in 2020.”

Based on Technology, Blood Screening Market is studied into Nucleic Acid Amplification (NAAT), Enzyme Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blotting, Next Generation Sequencing (NGS). In 2020, the Nucleic Acid Amplification (NAAT) category held the maximum proportion of the global blood screening market. The technology’s exceptional benefits, such as high sensitivity and specificity for early detection, account for most of the share.

“Amongst End User, Blood Banks holds significant market share in 2020.”

Based on End User, the Blood Screening Market is fragmented into Hospitals, Blood Banks, Others. The market for blood screening was dominated by the blood banks segment. Laboratory testing for infectious illnesses in donated blood and blood products is a critical safety step to safeguard patients and prevent the spread of dangerous infectious diseases. The growth of this segment is being driven by factors such as rising blood donations and transfusion-related tests, expanding awareness of transfusion-transmitted infections, and the rising occurrence of infectious disorders.

“North America represents as the largest market.”

For a better understanding of the market adoption of Blood Screening, the market is analyzed for the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), and Rest of World. North America dominated the market in 2020. Factors driving the North America Blood Screening Market include growing awareness of blood donations, the increasing incidence of infectious diseases, and the growing incidence of novel pathogens, and the presence of high-end infrastructure for hospitals and scientific laboratories, including the presence of key players in the region.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional & country-level analysis of the industry

Customization Options:

Blood Screening Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1Market Definitions
1.2Limitation
1.3Stake Holders
1.4Currency used in Report
2.1Research Process of the Blood Screening Market
2.2Research Methodology of the Blood Screening Market
2.3Forecasting Method
2.4Respondent Profile
2.5Main Objective of the Blood Screening Market Study
3MARKET SYNOPSIS

 

4EXECUTIVE SUMMARY
5BLOOD SCREENING MARKET COVID-19 IMPACT

 

6BLOOD SCREENING MARKET REVENUE, 2019-2027F

 

7.1   Reagents & Kits
7.2   Instruments
7.3   Software & Services
8.1Nucleic Acid Amplification (NAAT)
 8.1.1Transcription Mediated Amplification (TMA)
 8.1.2Real Time Polymerase Chain Reaction (RT-PCR)
8.2Enzyme Linked Immunosorbent Assay (ELISA)
 8.2.1Chemiluminescent Immunoassay (CLIA)
 8.2.2Fluorescent Immunoassays (FIA)
 8.2.3Colorimetric Immunoassays (CI)
8.3Rapid Tests
8.4Western Blotting
8.5Next Generation Sequencing (NGS)
9.1Hospitals
9.2Blood Banks
9.3Others
10.1NORTH AMERICA BLOOD SCREENING MARKET 
 10.1.1United States
 10.1.2Canada
 10.1.3Rest of North America
10.2EUROPE BLOOD SCREENING MARKET 
 10.2.1    United Kingdom
 10.2.2    Germany
 10.2.3    France
 10.2.4    Italy
 10.2.5    Spain
 10.2.6    Rest of Europe
10.3ASIA-PACIFIC BLOOD SCREENING MARKET 
 10.3.1China
 10.3.2Japan
 10.3.3India
 10.3.4Australia
 10.3.5Rest of Asia-Pacific
10.4REST OF WORLD BLOOD SCREENING MARKET 

 

11.1Market Drivers
11.2Market Challenges
11.3Impact Analysis
12BLOOD SCREENING MARKET OPPORTUNITIES

 

13BLOOD SCREENING MARKET TRENDS

 

14.1Company Shares, By Key Players
15.1Abbott Laboratories
15.2Bio-Rad Laboratories, Inc
15.3F. Hoffmann-La Roche Ltd
15.4Becton, Dickinson And Company
15.5Thermo Fisher Scientific Inc
15.6bioMerieux, Inc
15.7Grifols, S.A.
15.8Danaher Corporation
15.9Boster Biological Technology
15.10Demeditec Diagnostics GmbH
16DISCLAIMER

 

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future of the Blood Screening Market were the three major steps undertaken to create and analyze the adoption of blood screening products & technologies across various regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted, with industry experts across the value chain of the industry. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below.

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Blood Screening through company internal sources such as annual report & financial statements, investor presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Blood Screening, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are by product, by technology, and by end user. Further regional & country-level analyses were conducted to evaluate the overall adoption of the Blood Screening Market in the global context.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size. Further, we conducted factor analysis using dependent and independent variables such as increasing blood donations and transfusion-related screenings and the increasing prevalence of infectious diseases, etc. Historical trends and their year-on-year impact on the market size and share was analyzed. Demand and supply side scenario was also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Market, and market shares of the segments and company. All the required percentage split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of Blood Screening across the major markets
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Blood Screening Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major countries. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Blood Screening Market 3
Blood Screening Market 3

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Blood Screening Market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, technology, and end user for the major country/region globally.

The main objective of the Blood Screening Market Study

The current & future market trends of Blood Screening were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional & country level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Blood Screening in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include product, technology, and end user
  • Analyze the current and forecast market size of the Blood Screening for the major regions & countries
  • Major regions studied in the report include North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World
  • Company profiles of the Blood Screening Market players and the growth strategies adopted by them to sustain in the fast-growing market
  • Deep dive regional & country level analysis of the industry